CHICAGO, January 08, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results